Mussel-inspired dopamine-CuII coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis.

Nitric oxide (NO) is a highly potent, yet short-lived bioactive molecule with a broad spectrum of physiological functions. Continuous and controllable in situ generation of NO from vascular stent surface can effectively prevent restenosis and thrombosis after its implantation. In this study, inspired by the adhesion and protein cross-linking in the mussel byssus, through immersing the stents into an aqueous solution with dopamine (DA) and copper ions (CuII), we developed a one-step metal-catecholamine assembled strategy to prepare a durable in situ NO-generating biomimetic coating (DA-CuII). Due to the high NO catalytic efficacy and robust chelation of CuII into the DA-CuII network, the coated stents exhibited excellent hemocompatibility. The coating also catalytically decomposed endogenous S-nitrosothiols (RSNOs) from fresh blood, and locally generated NO for over 30 days with a flux comparable to its physiological range (0.5-4 × 10-10 mol × cm-2 × min-1). Moreover, the optimized biomimetic coatings displayed specific cell selectivity to significantly enhance endothelial cell (EC) growth while substantially inhibit smooth muscle cell (SMC) growth and migration. This feature impressively promoted regeneration of a new endothelial cell layer after stent implantation, hence improved the anti-thrombogenic and anti-restenosis qualities of vascular stents in vivo. We envision that our long-term in situ NO-generating coatings could serve as biosurfaces for long-term prevention of stent thrombosis and restenosis.

[1]  M. Schoenfisch,et al.  Nitric oxide release: part III. Measurement and reporting. , 2012, Chemical Society reviews.

[2]  Y. Weng,et al.  Copper-Incorporated Collagen/Catechol Film for in Situ Generation of Nitric Oxide. , 2015, ACS biomaterials science & engineering.

[3]  Hongfan Sun,et al.  The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent. , 2013, Biomaterials.

[4]  S. Nair,et al.  Stable Titania Nanostructures on Stainless Steel Coronary Stent Surface for Enhanced Corrosion Resistance and Endothelialization , 2017, Advanced healthcare materials.

[5]  A. W. Carpenter,et al.  Nitric oxide release: part II. Therapeutic applications. , 2012, Chemical Society reviews.

[6]  J. Chen,et al.  Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization. , 2014, Journal of biomedical materials research. Part A.

[7]  N. Huang,et al.  Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents. , 2018, Biomaterials.

[8]  M. Schoenfisch,et al.  Nitric oxide release: part I. Macromolecular scaffolds. , 2012, Chemical Society reviews.

[9]  A. de Mel,et al.  Nitric oxide: a guardian for vascular grafts? , 2011, Chemical reviews.

[10]  J. Ji,et al.  Surface-mediated functional gene delivery: an effective strategy for enhancing competitiveness of endothelial cells over smooth muscle cells. , 2013, Biomaterials.

[11]  Amedea B Seabra,et al.  State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications. , 2015, Biotechnology advances.

[12]  M. Stevens,et al.  Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide , 2018, ACS applied materials & interfaces.

[13]  E. Vogler,et al.  Reduced platelet adhesion and improved corrosion resistance of superhydrophobic TiO₂-nanotube-coated 316L stainless steel. , 2015, Colloids and surfaces. B, Biointerfaces.

[14]  M. Dong,et al.  Biomimetic cardiovascular stents for in vivo re-endothelialization. , 2016, Biomaterials.

[15]  H. Zhong,et al.  Evaluation of promoting effect of a novel Cu-bearing metal stent on endothelialization process from in vitro and in vivo studies , 2017, Scientific Reports.

[16]  Qiufen Tu,et al.  Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices. , 2012, Biomaterials.

[17]  G. Stone,et al.  Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[18]  N. Huang,et al.  Catalytic Formation of Nitric Oxide Mediated by Ti–Cu Coatings Provides Multifunctional Interfaces for Cardiovascular Applications , 2018 .

[19]  B. Mutus,et al.  Platelet cell-surface protein disulphide-isomerase mediated S-nitrosoglutathione consumption. , 2004, The Biochemical journal.

[20]  Alexander M Seifalian,et al.  Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology. , 2013, Biotechnology advances.

[21]  Achala de Mel,et al.  Nitric oxide donors for cardiovascular implant applications. , 2013, Small.

[22]  Kyung Seob Lim,et al.  Nitric Oxide Releasing Coronary Stent: A New Approach Using Layer-by-Layer Coating and Liposomal Encapsulation. , 2016, Small.

[23]  M. Meyerhoff,et al.  Catalytic generation of nitric oxide from S-nitrosothiols using immobilized organoselenium species. , 2007, Biomaterials.

[24]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[25]  Y. Yoon,et al.  Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion under Physiologic Conditions. , 2018, ACS biomaterials science & engineering.

[26]  A. Matzger,et al.  Origin of Long-Term Storage Stability and Nitric Oxide Release Behavior of CarboSil Polymer Doped with S-Nitroso-N-acetyl-d-penicillamine , 2015, ACS applied materials & interfaces.

[27]  Melissa M. Reynolds,et al.  Sustained Nitric Oxide Release from a Tertiary S-Nitrosothiol-based Polyphosphazene Coating. , 2017, ACS applied materials & interfaces.

[28]  N. Huang,et al.  Insights into the aggregation/deposition and structure of a polydopamine film. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[29]  Nan Huang,et al.  In vitro investigation of enhanced hemocompatibility and endothelial cell proliferation associated with quinone-rich polydopamine coating. , 2013, ACS applied materials & interfaces.

[30]  Y. Weng,et al.  Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents. , 2015, Biomaterials.

[31]  Qingbo Xu,et al.  Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Y. Weng,et al.  Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents. , 2011, Biomaterials.

[33]  N. Lotan,et al.  The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier. , 2014, Acta biomaterialia.

[34]  Ghaith Altawallbeh,et al.  Functional Layer-by-Layer Thin Films of Inducible Nitric Oxide (NO) Synthase Oxygenase and Polyethylenimine: Modulation of Enzyme Loading and NO-Release Activity. , 2018, ACS applied materials & interfaces.

[35]  Alan D. Lopez,et al.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 , 2017, Journal of the American College of Cardiology.

[36]  J. Goldman,et al.  Transition-Metal-Mediated Release of Nitric Oxide (NO) from S-Nitroso-N-acetyl-d-penicillamine (SNAP): Potential Applications for Endogenous Release of NO at the Surface of Stents Via Corrosion Products. , 2016, ACS applied materials & interfaces.

[37]  N. Huang,et al.  Synergetic coordination and catecholamine chemistry for catalytic generation of nitric oxide on vascular stents , 2018, NPG Asia Materials.

[38]  Qiufen Tu,et al.  Mussel‐Inspired Coating of Polydopamine Directs Endothelial and Smooth Muscle Cell Fate for Re‐endothelialization of Vascular Devices , 2012, Advanced healthcare materials.

[39]  T. Matsuda,et al.  Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model. , 2014, Journal of interventional cardiology.

[40]  N. Huang,et al.  Effects of polydopamine functionalized titanium dioxide nanotubes on endothelial cell and smooth muscle cell. , 2014, Colloids and surfaces. B, Biointerfaces.

[41]  Xiwen He,et al.  A self-assembled polydopamine film on the surface of magnetic nanoparticles for specific capture of protein. , 2012, Nanoscale.

[42]  J. Hothersall,et al.  Role of a copper (I)‐dependent enzyme in the anti‐platelet action of S‐nitrosoglutathione , 1996, British journal of pharmacology.

[43]  Qiufen Tu,et al.  Gallic acid tailoring surface functionalities of plasma-polymerized allylamine-coated 316L SS to selectively direct vascular endothelial and smooth muscle cell fate for enhanced endothelialization. , 2014, ACS applied materials & interfaces.

[44]  Jian-ping Xu,et al.  Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation. , 2013, Biomaterials.

[45]  G. Ameer,et al.  Polymer‐Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications , 2012, Advanced functional materials.

[46]  J. Ji,et al.  Electropolymerization of dopamine for surface modification of complex-shaped cardiovascular stents. , 2014, Biomaterials.

[47]  Ping Yang,et al.  The Effects of Cu-doped TiO2 Thin Films on Hyperplasia, Inflammation and Bacteria Infection , 2015 .